おすすめの製品
詳細
non-ionic
品質水準
形状
solid
分子量
average Mn ~4,670
環境により配慮した代替製品の特徴
Use of Renewable Feedstocks
Design for Degradation
Learn more about the Principles of Green Chemistry.
sustainability
Greener Alternative Product
不純物
≤1.0% water
mp
51-54 °C (lit.)
酸性度指数
≤2.0 mg KOH/g
ヒドロキシル価
13‑25 mg KOH/g
密度
1.1 g/mL at 25 °C (lit.)
HLB
18.8
環境により配慮した代替製品カテゴリ
InChI
1S/C20H41O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-19-22-20-18-21/h2-20H2,1H3
InChI Key
PSEGVHKUPXNGGJ-UHFFFAOYSA-N
類似した製品をお探しですか？ 訪問 製品比較ガイド
関連するカテゴリー
詳細
ECO Brij® S100 is an ethoxylated natural fatty alcohol, a nonionic bio-based surfactant that belongs to the class of polyoxyethylene ethers. This naturally derived detergent offers a number of functional benefits including detergency, wetting, and dispersing making it suitable for a range of applications in biochemical and biological research.
We are committed to bringing you Greener Alternative Products, which adhere to one or more of The 12 Principles of Green Chemistry. This product is a biobased surfactant and is aligned with the 7th principle of Green Chemistry "Use of Renewable Feedstocks" and the 10th principle "Design for Degradation".
特徴および利点
- 100 % Renewable
- 100 % Bio-based
- Certified to the USDA BioPreferred Program
- Lower carbon footprint than petrochemical-based versions
- High-purity chemical suitable for a wide variety of research applications
その他情報
For additional information on our range of Biochemicals, please complete this form.
法的情報
Brij is a registered trademark of Croda International PLC
ECO BRIJ is a registered trademark of Croda Inc.
シグナルワード
Warning
危険有害性情報
危険有害性の分類
Acute Tox. 4 Oral
保管分類コード
11 - Combustible Solids
WGK
WGK 2
引火点(°F)
Not applicable
引火点(℃)
Not applicable
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
Jan Code
STS0216-250G:
STS0216-VAR:
STS0216-BULK:
STS0216-1KG:
最新バージョンのいずれかを選択してください：
Anne Huhtala et al.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 19(1), 11-21 (2003-03-22)
This study was undertaken to investigate the use of the in vitro test WST-1, an assay of cell proliferation and viability, for a preliminary safety evaluation of topical ophthalmic preparations. The cytotoxicity of two surfactants, benzalkonium chloride (BAC) and polyoxyethylene-20-stearyl
Jae-Haeng Song et al.
Drug development and industrial pharmacy, 35(8), 897-903 (2009-02-26)
The oral administration of loratadine, an antihistamine, can have a variety of adverse side effects, such as headache, fatigue, and nausea, because of the transient high blood concentration. To avoid these effects, loratadine can be administered using a transdermal drug
S O Williams et al.
Drug development and industrial pharmacy, 26(1), 71-77 (2000-04-01)
The purpose of this study was to scale up an oil/water (o/w) cream formulation containing 40% diethylene glycol monoethyl ether (DGME), developed via 300-g laboratory batches in a 2(5-2) fractional factorial design, to 7-kg batch sizes in a Brogli-10 homogenizer.
J Q Zhang et al.
Drug delivery, 14(6), 381-387 (2007-08-19)
The study describes the development of stealth solid lipid nanoparticles (SLNs) as colloidal carriers for silibinin, a drug with very low solubility. Stealth SLNs were constituted mainly of bioacceptable and biodegradable lipids, such as stearic acid and surfactant Brij 78
Tatsuaki Tagami et al.
Journal of controlled release : official journal of the Controlled Release Society, 161(1), 142-149 (2012-04-17)
Here we report the development of an enhanced thermosensitive formulation composed of DPPC and Brij78, loaded with doxorubicin (DOX) using a Cu²⁺ gradient and post-inserted with an additional amount of Brij78. This optimal formulation (HaT-II: Hyperthermia-activated cytoToxic) displayed significantly improved
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）